Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: A prospective multi-institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA)-Reference-Cited by-同舟云学术

Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: A prospective multi-institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA)

Published:2014-03-20 Issue:8 Volume:61 Page:1403-1410
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Al-Mulla Naima A.¹,Chandra Prem²,Khattab Mohammed³,Madanat Faris⁴,Vossough Parvaneh⁵,Torfa Eyad⁶,Al-Lamki Zakiya⁷,Zain Gamal⁸,Muwakkit Samar⁹,Mahmoud Salah¹⁰,Al-Jassmi Abdulrahman¹¹,Tuncer Murat¹²,Al-Mukharraq Hussein¹³,Barsaoui Sihem¹⁴,Arceci Robert J.¹⁵,Howard Scott C.¹⁶,Kulozik Andreas E.¹⁷,Ravindranath Yaddanapudi¹⁸,Reaman Gregory H.¹⁹,Farranoush Mohammad⁵,AlNasser Abdullah A.¹

Affiliation:

1. Department of Pediatrics; Section of Hematology/Oncology; Doha Qatar

2. Medical Research Center; Hamad Medical Corporation; Doha Qatar

3. Pediatric Hematology and Oncology Center; CH Ibn Sina; University Mohammed V Souissi; Rabat Morocco

4. Pediatric Hematology Oncology Section; King Hussein Cancer Center; Amman Jordan

5. Pediatric Oncology; Ali Asghar Children's Hospital Iran University Medical Sciences; Tehran Iran

6. Pediatric Hematology Oncology; Children's Hospital; Damascus Syria

7. Sultan Qaboos University; Child Health Department College of Medicine; Muscat Oman

8. Al Wahda Teaching Hospital; Pediatric Hematologist Oncologist; Aden Cancer Center; Aden Yemen

9. Pediatric Hematology/Oncology; American University of Beirut; Medical Center-St. Jude Children Cancer Center of Lebanon; Beirut Lebanon

10. Pediatric Hematology Service; National Cancer Institute; Cairo Egypt

11. Pediatric Hematology Oncology; Dubai Hospital; Dubai UAE

12. Department of Cancer Control; Ministry of Health; Ankara Turkey

13. Pediatric Hematologist Oncologist; Salmaniya Medical Complex Ministry of Health; Manama Bahrain

14. Pediatric Oncology; Children's Hospital Service de Medicine Infantile A; Tunis Tunisia

15. Ron Matricaria Institute of Molecular Medicine at Phoenix Children's Hospital; University of Arizona College of Medicine; Phoenix Arizona

16. Department of Oncology; St. Jude Children's Research Hospital; Memphis Tennessee

17. Department of Pediatric Oncology; Hematology & Immunology; Children's Hospital; Heidelberg Germany

18. Professor of Pediatrics; Georgie Ginopolis Chair for Pediatric Cancer and Hematology; Wayne State University; Detroit Michigan

19. Center for Cancer and Blood Disorders; Children's National Medical Center; Washington District of Columbia

Funder

QNRF-National Priority Research Project

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25031/fullpdf

Reference22 articles.

1. Improved outcome for children with acute lymphoblastic leukemia after risk-adjusted intensive therapy: Single-institution experience;Al-Nasser;Ann Saudi Med,2008

2. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia in the kingdom of Saudi Arabia: A multi-institutional national collaborative study;Al-Sudairy;Pediatr Blood Cancer,2014

3. Childhood acute lymphoblastic leukemia in Turkey: Factors influencing treatment and outcome: Single center experience;Hazar;Pediatr Hematol Oncol,2010

4. Characterization of acute lymphoblastic leukemia subtypes in Moroccan children. International;Bachir;J Pediatr,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caspase 3 Expressions in Children with Acute Lymphoblastic Leukemia During Induction Phase Chemotherapy;Malaysian Journal of Medicine and Health Sciences;2023-05-15

2. Comprehensive genetic analyses of childhood acute leukemia in Iraq using next-generation sequencing;Translational Pediatrics;2023-05

3. How should childhood acute lymphoblastic leukemia relapses in low‐income and middle‐income countries be managed: The AHOPCA‐ALL study group experience;Cancer;2022-12-12

4. Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage;JCO Global Oncology;2022-05

5. Is hypoalbuminemia a risk factor for high-dose methotrexate toxicity in children with acute lymphoblastic leukemia?;Journal of the Egyptian National Cancer Institute;2022-04-18